Escalating de-escalation in breast cancer treatment Virgilio SacchiniLarry Norton Editorial 28 July 2022 Pages: 85 - 90
Intermedin (adrenomedullin 2) promotes breast cancer metastasis via Src/c-Myc-mediated ribosome production and protein translation Lingmiao KongYing XiongWei Zhang Preclinical study 28 July 2022 Pages: 91 - 103
MYC as a therapeutic target for the treatment of triple-negative breast cancer: preclinical investigations with the novel MYC inhibitor, MYCi975 Minhong TangShane O’GradyMichael J. Duffy Preclinical study Open access 30 July 2022 Pages: 105 - 115
Relations between recurrence risk perceptions and fear of cancer recurrence in breast cancer survivors J. W. AnkersmidF. K. Lansink RotgerinkC. H. C. Drossaert Preclinical study Open access 30 July 2022 Pages: 117 - 125
Analysis of patients without and with an initial triple-negative breast cancer diagnosis in the phase 3 randomized ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer Joyce O’ShaughnessyAdam BrufskyJavier Cortés Clinical trial Open access 11 May 2022 Pages: 127 - 139
Acceptability of a companion patient guide to support expert consensus guidelines on surveillance mammography in older breast cancer survivors Rachel A. FreedmanAnna C. RevetteMara A. Schonberg Clinical trial 30 July 2022 Pages: 141 - 152
Primary care physician referral practices regarding BRCA1/2 genetic counseling in a major health system Debra T. LinfieldMichael B. RothbergKathryn A. Martinez Epidemiology 16 July 2022 Pages: 153 - 160
Non-invasive predictors of axillary lymph node burden in breast cancer: a single-institution retrospective analysis Victoria NgaiJustina Cheh Juan TaiMuneer Ahmed Epidemiology Open access 21 July 2022 Pages: 161 - 169
Trastuzumab therapy duration in HER2-positive de novo metastatic breast cancer: 1999–2018 Henry G. KaplanJudith A. MalmgrenMary K. Atwood Epidemiology Open access 22 July 2022 Pages: 171 - 180
Rates of pathologic nodal disease among cN0 and cN1 patients undergoing routine axillary ultrasound and neoadjuvant chemotherapy Anna WeissClaire KingTari A. King Epidemiology 28 July 2022 Pages: 181 - 189
A prognostic survival model for women diagnosed with invasive breast cancer in Queensland, Australia Peter D BaadeHelen FowlerJoanne F Aitken Epidemiology Open access 28 July 2022 Pages: 191 - 200
Risk of recurrence and pregnancy outcomes in young women with breast cancer who do and do not undergo fertility preservation Ying WangMegan E. TeschCaroline A. Lohrisch Epidemiology 30 July 2022 Pages: 201 - 208
Cancer-specific mortality in breast cancer patients with hypothyroidism: a UK population-based study Lauren McVickerChristopher R. CardwellÚna C. McMenamin Epidemiology Open access 31 July 2022 Pages: 209 - 221
